|
|
|
|
LEADER |
01608nam a2200265 u 4500 |
001 |
EB002219832 |
003 |
EBX01000000000000001356793 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
240703 r ||| eng |
100 |
1 |
|
|a DiMarco, Daniela E.
|
245 |
0 |
0 |
|a Doxycycline post-exposure prophylaxis to prevent bacterial sexually transmitted infections
|h Elektronische Ressource
|c c Clinical Guidelines Program, New York State Department of Health AIDS Institute ; lead authors, Daniela E. DiMarco, Marguerite A. Urban
|
246 |
3 |
1 |
|a Doxycyckube opost-exposure prophylaxis to prevent bacterial STIs
|
260 |
|
|
|a [New York]
|b New York State Department of Health AIDS Institute
|c 2023, September 25, 2023
|
300 |
|
|
|a 1 PDF file (14 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
700 |
1 |
|
|a Urban, Marguerite A.
|e [author]
|
710 |
2 |
|
|a Clinical Guidelines Program
|
710 |
2 |
|
|a New York (State)
|b AIDS Institute
|
710 |
2 |
|
|a New York (State)
|b AIDS Institute
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK597440
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a This guideline on the use of doxycycline post-exposure prophylaxis (doxy-PEP) for prevention of bacterial sexually transmitted infections (STIs), including syphilis, chlamydia, and gonorrhea, was developed by the New York State Department of Health AIDS Institute (NYSDOH AI) Clinical Guidelines Program to support clinicians in caring for adults and adolescents with and without HIV who are at risk of STIs
|